Explore more publications!
Africa News Guide
Got News to Share?

Africa News Guide: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Guide.

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

Press releases published on February 4, 2026

XORTX Provides Update on Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems
Feb. 4, 2026

XORTX Provides Update on Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems

Indeterminate GlobeNewswire
Integra Announces US$55 Million Bought Deal Financing
Feb. 4, 2026

Integra Announces US$55 Million Bought Deal Financing

Indeterminate GlobeNewswire
Tempest Announces Closing of Strategic Acquisition of Dual-Targeting CAR-T Assets
Feb. 4, 2026

Tempest Announces Closing of Strategic Acquisition of Dual-Targeting CAR-T Assets

Indeterminate GlobeNewswire
Revolution Medicines to Participate in Guggenheim Securities Emerging Outlook: Biotech Summit 2026
Feb. 4, 2026

Revolution Medicines to Participate in Guggenheim Securities Emerging Outlook: Biotech Summit 2026

Indeterminate GlobeNewswire
Relay Therapeutics to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026
Feb. 4, 2026

Relay Therapeutics to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026

Indeterminate GlobeNewswire
Lesaka’s Q2 FY2026 Results: Lesaka achieves mid-point of its profitability guidance and reaffirms its FY2026 full year guidance
Feb. 4, 2026

Lesaka’s Q2 FY2026 Results: Lesaka achieves mid-point of its profitability guidance and reaffirms its FY2026 full year guidance

Indeterminate GlobeNewswire
PROCEPT BioRobotics® to Attend the TD Cowen 46th Annual Health Care Conference and the 2026 Leerink Global Healthcare Conference
Feb. 4, 2026

PROCEPT BioRobotics® to Attend the TD Cowen 46th Annual Health Care Conference and the 2026 Leerink Global Healthcare Conference

Indeterminate GlobeNewswire
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Feb. 4, 2026

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Crop Protection Chemicals Market Booming with Rapid Growth Through 2033 | FMC Corporation, Nufarm Ltd
Feb. 4, 2026

Crop Protection Chemicals Market Booming with Rapid Growth Through 2033 | FMC Corporation, Nufarm Ltd

Indeterminate EIN Presswire
Lumina Greenland to Nearly Double Mining Operations with New Equipment Delivery 
Feb. 4, 2026

Lumina Greenland to Nearly Double Mining Operations with New Equipment Delivery 

Indeterminate GlobeNewswire
2026: The year IoT became core infrastructure
Feb. 4, 2026

2026: The year IoT became core infrastructure

Indeterminate EIN Presswire
Dewpoint Therapeutics Doses First Patient in Phase 1a/2a Trial DPTX3186 for the Treatment of Advanced Solid Tumors, Focused on Gastric Cancer
Feb. 4, 2026

Dewpoint Therapeutics Doses First Patient in Phase 1a/2a Trial DPTX3186 for the Treatment of Advanced Solid Tumors, Focused on Gastric Cancer

Indeterminate GlobeNewswire
Globex Reports Additional High-Grade Gold in Drilling on it’s Nordeau Royalty Claims
Feb. 4, 2026

Globex Reports Additional High-Grade Gold in Drilling on it’s Nordeau Royalty Claims

Indeterminate GlobeNewswire
Globex rapporte de nouvelles hautes teneurs aurifères en forage sur les titres de la propriété à redevance Nordeau
Feb. 4, 2026

Globex rapporte de nouvelles hautes teneurs aurifères en forage sur les titres de la propriété à redevance Nordeau

Indeterminate GlobeNewswire
GRI Bio Reiterates Full Year 2025 Financial Results, Strengthens Balance Sheet and Summarizes Key Recent Highlights
Feb. 4, 2026

GRI Bio Reiterates Full Year 2025 Financial Results, Strengthens Balance Sheet and Summarizes Key Recent Highlights

Indeterminate GlobeNewswire
Biodexa Announces Exclusive License of Otsuka’s OPB-171775, a potent Phase 1 ready Molecular Glue for GIST
Feb. 4, 2026

Biodexa Announces Exclusive License of Otsuka’s OPB-171775, a potent Phase 1 ready Molecular Glue for GIST

Indeterminate GlobeNewswire
Veru to Report Fiscal 2026 First Quarter Financial Results on February 11th
Feb. 4, 2026

Veru to Report Fiscal 2026 First Quarter Financial Results on February 11th

Indeterminate GlobeNewswire
Aprea Therapeutics Appoints Industry Veteran Eugene Kennedy, MD, as Chief Medical Advisor
Feb. 4, 2026

Aprea Therapeutics Appoints Industry Veteran Eugene Kennedy, MD, as Chief Medical Advisor

Indeterminate GlobeNewswire
RenovoRx Announces Clinical Data Supporting the TAMP™ Therapy Platform will be Presented at the SIO 2026 Annual Scientific Meeting
Feb. 4, 2026

RenovoRx Announces Clinical Data Supporting the TAMP™ Therapy Platform will be Presented at the SIO 2026 Annual Scientific Meeting

Indeterminate GlobeNewswire
OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism
Feb. 4, 2026

OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions